EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Multi‐Omics Biomarker Signatures for Precision Diagnosis and Prognosis in Primary Liver Cancer: A Literature Review

Ke Xu iD, Yu Liu, Yuan Peng iD, Yanli Zeng, Zhibin Luo

BioFactors · 2026-09 · 52 (5)

DOI: 10.1002/biof.70136 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioFactors, online erschienen am 04.09.2026. Verfasst von Ke Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Chongqing General Hospital, Chongqing University, Chongqing, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Biomarkers, Tumor, Carcinoma, Hepatocellular, Cholangiocarcinoma. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science and Technology Research Program of Chongqing Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary liver cancer (PLC) is a biologically heterogeneous group of malignancies dominated by hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (iCCA), and a smaller subset of combined hepatocellular‐cholangiocarcinoma (cHCC‐CCA), and its clinical burden remains high because current diagnostic and prognostic tools do not adequately capture molecular diversity. Conventional imaging, serum markers, and histopathological assessment remain insufficient for precise early diagnosis, subtype‐resolved classification, and outcome stratification, while tissue and liquid biopsy approaches have expanded the range of analytes available for clinical assessment. Recent studies have identified candidate biomarker signatures across genomic, epigenomic, transcriptomic, proteomic, metabolomic, and circulating layers, suggesting that integrated multi‐omics profiling may better represent tumor lineage, clonal evolution, immune context, and therapeutic vulnerability than isolated molecular readouts. However, these layers are not equally mature for clinical use: genomic testing is closest to routine therapeutic application in iCCA, plasma methylation assays are advancing for HCC surveillance augmentation, and many proteomic or metabolomic panels remain validation‐stage tools. Their clinical value remains constrained by sampling bias, biospecimen‐dependent signal loss, assay standardization, cost, and the need for prospective validation across clinically diverse populations. This narrative review critically synthesizes current evidence on multi‐omics biomarker signatures for precision diagnosis and prognosis in primary liver cancer and argues that clinically useful signatures should be question‐specific, stage‐aware, and specimen‐aware rather than universal multi‐analyte panels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsBiomarkers, TumorCarcinoma, HepatocellularCholangiocarcinomaHumansMultiomicsPrognosisProteomics

Stichwörter der Autor:innen

biomarker signaturesmolecular stratificationmulti‐omicsnarrative reviewprecision diagnosisprimary liver cancertranscriptomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oncology, Chongqing General Hospital, Chongqing University, Chongqing, China.

ORCID-Profile: Ke Xu, Yuan Peng

Förderung

  • Science and Technology Research Program of Chongqing Municipal Education Commission

Zitieren

APA

Xu, K., Liu, Y., Peng, Y., Zeng, Y., & Luo, Z. (2026). Multi‐Omics Biomarker Signatures for Precision Diagnosis and Prognosis in Primary Liver Cancer: A Literature Review. BioFactors, 52(5). https://doi.org/10.1002/biof.70136

Vancouver

Xu K, Liu Y, Peng Y, Zeng Y, Luo Z. Multi‐Omics Biomarker Signatures for Precision Diagnosis and Prognosis in Primary Liver Cancer: A Literature Review. BioFactors. 2026;52(5). doi:10.1002/biof.70136

BibTeX
@article{Xu2026,
  author = {Xu, Ke and Liu, Yu and Peng, Yuan and Zeng, Yanli and Luo, Zhibin},
  title = {Multi‐Omics Biomarker Signatures for Precision Diagnosis and Prognosis in Primary Liver Cancer: A Literature Review},
  journal = {BioFactors},
  year = {2026},
  volume = {52},
  number = {5},
  doi = {10.1002/biof.70136}
}
Kostenlos starten →